Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:1885
TSE:1885Construction

How Investors Are Reacting To TOA (TSE:1885) ESG KPI Revisions And ¥50B Growth Investment Plan

Earlier in 2026, Toa Corporation released a three-year medium-term management plan for fiscal 2026–2028, outlining ¥50,000,000,000 of investment to expand its core civil engineering operations, enter areas such as defense, carbon capture and offshore wind, and commit to a payout ratio of at least 40% with flexible share buybacks. Shortly afterward, the company corrected inaccurate non-financial sustainability KPIs in the plan, highlighting a sharpened focus on transparent ESG reporting for...
NasdaqGS:MOMO
NasdaqGS:MOMOInteractive Media and Services

Hello Group (MOMO) Margin Slide To 7.8% Tests Bullish Earnings Narrative

Hello Group (NasdaqGS:MOMO) has just wrapped up FY 2025 with fourth quarter revenue of C¥2,575.8 million and basic EPS of C¥1.46, set against a trailing twelve month tally of C¥10.4 billion in revenue and basic EPS of C¥4.84. Over the past six reported quarters, revenue has moved between C¥2,520.8 million and C¥2,674.7 million, while quarterly basic EPS has ranged from a loss of C¥0.84 to a high of C¥2.58. This gives investors a clear view of how earnings have tracked through the year. With...
NYSE:SPIR
NYSE:SPIRProfessional Services

Spire Global (SPIR) Quarterly Loss Revives Concerns Over Sustainability Of Trailing Profitability

Spire Global (SPIR) closed out FY 2025 with Q4 revenue of US$15.8 million, a basic EPS loss of US$0.76, and a net loss of US$25.1 million, against a backdrop of trailing 12 month revenue of US$71.6 million and basic EPS of US$1.66. Over recent quarters the company has seen quarterly revenue range from US$23.9 million in Q1 2025 to US$12.7 million in Q3 2025, while quarterly EPS has swung between a US$3.80 profit in Q2 2025 and losses such as US$1.90 in Q4 2024. This sets up a complex picture...
NYSE:HL
NYSE:HLMetals and Mining

Are Greens Creek Gains Quietly Rewriting Hecla Mining’s (HL) Long‑Term Risk and Asset Story?

Hecla Mining recently reported strong fourth-quarter 2025 results, improved leverage, and positive test outcomes at its Greens Creek Mine, indicating better metal recoveries and lower environmental liabilities. These operational gains, paired with plans to increase exploration and advance Keno Hill toward commercial output by 2027, suggest a business focused on strengthening its asset base and long-term production profile. Next, we’ll examine how Greens Creek’s higher recovery rates and...
BIT:A2A
BIT:A2AIntegrated Utilities

A2A (BIT:A2A) Margin Compression In FY 2025 Challenges Long Term Bullish Narratives

A2A FY 2025 earnings snapshot A2A (BIT:A2A) just wrapped up FY 2025 with fourth quarter revenue of €3.9b and net income of €169m, rounding out a trailing twelve month picture of €14.0b in revenue and €750m in net income. Over recent quarters, the company has seen revenue move from €3.5b and net income of €151m in Q4 2024 to €3.9b and €169m in Q4 2025, while trailing EPS shifted from €0.28 to €0.26. This sets up a results season in which income-focused investors will pay close attention to how...
NYSE:UBER
NYSE:UBERTransportation

Uber Balances Argentina Growth Plans With New Pricing Lawsuit Risks

Uber Technologies (NYSE:UBER) has pledged to invest $500 million in Argentina over the next three years, expanding its presence in Latin America. The company is also facing a new U.S. class action lawsuit that accuses Uber of systematically overcharging riders for faster ride arrival times. Uber trades at $76.66, with the share price up 2.3% over the past week and 9.5% over the past month. Over the past three years, the stock has returned 143.2%, while the five year return stands at 45.8%...
NasdaqGS:IPGP
NasdaqGS:IPGPElectronic

Did a Narrow UPC Patent Loss Just Reframe IPG Photonics' (IPGP) Competitive Moat in Lasers?

In March 2026, IPG Photonics reported that the Unified Patent Court in Düsseldorf ruled certain uses and designs of its adjustable mode beam lasers infringed a Trumpf European patent, potentially exposing the company to remedies such as injunctions, recalls and damages in Germany, France and Italy. Although the ruling currently affects less than 1% of IPG's total sales, it introduces legal and operational uncertainty around a specialized product line that sits within the company's broader...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Opendoor Weighs Mortgage Deregulation Tailwinds Against Profitability And Dilution Risks

White House issues an executive order that deregulates parts of the mortgage industry and expands credit access for homebuyers. Opendoor Technologies (NasdaqGS:OPEN) responds by leaning into its new 4.99% fixed-rate mortgage program to attract more buyers. Management, including new CEO Kaz Nejatian, highlights quicker inventory turnover, contribution margin improvements, and deeper use of artificial intelligence. Opendoor Technologies, the online home buying and selling platform, sits at...
BIT:MOL
BIT:MOLConsumer Finance

Moltiply Group (BIT:MOL) Quarterly Loss Challenges Bullish Earnings Growth Narrative

Moltiply Group (BIT:MOL) closed out FY 2025 with fourth quarter revenue of €224.1 million and net income from continuing operations of €9.2 million, alongside trailing twelve month revenue of €706.9 million and €29.2 million of net income. EPS over the same trailing period came in at €0.75. The company’s quarterly revenue increased from €136.9 million in Q4 2024 to €224.1 million in Q4 2025, while quarterly net income moved from €13.4 million a year ago to a loss of €9.2 million in the latest...
SWX:MED
SWX:MEDMedical Equipment

Medartis Holding (SWX:MED) Half Year Loss Challenges High Growth Profitability Narrative

Medartis Holding (SWX:MED) opened FY 2025 with first half revenue of CHF123.0 million and a basic EPS loss of CHF0.12, while trailing twelve month figures show revenue of CHF269.3 million and basic EPS of CHF0.67. Over the last few reported periods, revenue has moved from CHF111.5 million in H1 2024 to CHF113.3 million in H2 2024 and then to CHF123.0 million in H1 2025. Basic EPS shifted from CHF0.21 in H1 2024 to CHF0.09 in H2 2024 before dipping into a loss of CHF0.12 in H1 2025, putting...
NYSE:SPGI
NYSE:SPGICapital Markets

S&P Global Flags Copper Squeeze Risk For AI Data Centre Growth

S&P Global (NYSE:SPGI) has issued a new forecast that global copper demand could be 50% higher by 2040. The company highlights AI data centre construction as a key driver of this expected demand shift. S&P Global also warns of a potential copper supply crunch that could affect the buildout of AI infrastructure. S&P Global, trading at around $426.64, is drawing attention not just for its role in financial data but also for its commodity research. The company is flagging copper as a potential...
NasdaqGS:HTHT
NasdaqGS:HTHTHospitality

H World Group (NasdaqGS:HTHT) Margin Expansion Challenges Bearish Profitability Narratives

H World Group (NasdaqGS:HTHT) closed out FY 2025 with Q4 revenue of C¥6.5b and basic EPS of C¥3.82, alongside trailing twelve month revenue of C¥25.3b and EPS of C¥16.54 that followed reported earnings growth of 66.7% over the past year. Over recent quarters the company has seen revenue range from C¥5.4b in Q1 2025 to C¥7.0b in Q3 2025, with quarterly EPS moving between C¥2.92 and C¥5.03, while trailing net profit margin sat at 20.1% compared with 12.8% a year earlier. For investors, that...
XTRA:MUM
XTRA:MUMSoftware

Mensch Und Maschine Software XTRA MUM Margin Expansion Reinforces Bullish Earnings Narrative

Mensch und Maschine Software FY 2025 earnings snapshot Mensch und Maschine Software (XTRA:MUM) has wrapped up FY 2025 with fourth quarter revenue of €61.5 million, basic EPS of €0.47 and net income of €7.8 million, setting the tone against a trailing twelve month EPS of €1.91 on revenue of €238.6 million and net income of €31.8 million. Over recent periods the company has seen quarterly revenue move from €55.8 million and EPS of €0.36 in Q4 2024 to €61.5 million and EPS of €0.47 in Q4 2025,...
NasdaqCM:CLPT
NasdaqCM:CLPTMedical Equipment

ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses

ClearPoint Neuro (CLPT) just posted its FY 2025 numbers with Q4 revenue of US$10.4 million, a basic EPS loss of US$0.27, and trailing twelve month revenue of US$37.0 million alongside a trailing EPS loss of US$0.90. Over recent periods, the company has seen quarterly revenue move from US$7.8 million in Q4 2024 to US$10.4 million in Q4 2025, while quarterly EPS losses shifted from US$0.20 to US$0.27 over the same stretch. For investors, the update sets solid top line progress against ongoing...
NasdaqCM:OVID
NasdaqCM:OVIDBiotechs

Ovid Therapeutics (OVID) Q4 Profit Challenges Ongoing Loss Narrative

Ovid Therapeutics (OVID) closed FY 2025 with fourth quarter revenue of US$0.72 million and basic EPS of US$0.12, alongside trailing twelve month revenue of US$7.25 million and a trailing basic EPS loss of US$0.24. Over the past year, the company has seen quarterly revenue move from US$0.08 million in Q4 2024 to US$6.27 million in Q2 2025 and US$0.72 million in Q4 2025. Basic EPS has ranged from a loss of US$0.20 in Q3 2024 to a loss of US$0.17 in Q3 2025 and a profit of US$0.12 in Q4 2025...
TSE:1803
TSE:1803Construction

Shimizu (TSE:1803) Valuation After Follow On Offering And Leadership Changes

Shimizu (TSE:1803) has drawn fresh attention after filing a follow on equity offering of 14,137,200 ordinary shares, together with board approved retirements of several senior executives and outside directors. See our latest analysis for Shimizu. At a share price of ¥3,092.0, Shimizu has recorded a 17.25% 90 day share price return and a very large 3 year total shareholder return, suggesting momentum has been strong even with a softer 30 day move. If this kind of construction and...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Did Ionis Pharmaceuticals' (IONS) Board Refresh and Return of Peter Reikes Just Shift Its Investment Narrative?

Ionis Pharmaceuticals recently announced that long-serving directors B. Lynne Parshall and Joseph Wender will retire from its board in June 2026, with former director and healthcare investment banker Peter N. Reikes rejoining after senior advisory roles at ARPA-H and the US FDA. The board refresh brings in renewed regulatory and capital-markets expertise at a time when Ionis is preparing for multiple potential launches and late-stage clinical milestones. We’ll now examine how the addition of...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

Assessing SoFi Technologies (SOFI) Valuation After Recent Share Price Weakness

Why SoFi Technologies (SOFI) Is on Investors’ Radar Today SoFi Technologies (SOFI) is back in focus after a recent pullback, with the stock showing a 1 day return of about a 1% decline and a past 3 months return near a 35% decline. Investors are weighing these moves against its multi segment financial services model. See our latest analysis for SoFi Technologies. While the recent 7 day and 90 day share price returns of about a 7% and 35% decline suggest fading short term momentum, the 1 year...
TASE:BIG
TASE:BIGReal Estate

Big Shopping Centers (TASE:BIG) One Off ₪1.4b Gain Tests Bullish Earnings Narratives

BIG Shopping Centers (TASE:BIG) has just wrapped up FY 2025 with fourth quarter revenue of ₪584.8 million and basic EPS of ₪21.70, set against trailing 12 month EPS of ₪70.98 on revenue of ₪2.9 billion. Over recent periods the company has seen quarterly revenue range from ₪744.2 million to ₪773.5 million and basic EPS move between ₪10.07 and ₪27.33, giving investors a clear view of how the top line and per share earnings have tracked into the latest full year numbers. With a current share...
NasdaqGS:MAR
NasdaqGS:MARHospitality

A Look At Marriott International (MAR) Valuation After Kapalua Bay Luxury Expansion News

Marriott International (MAR) has drawn fresh attention after signing an agreement with Kemmons Wilson Hospitality Partners to bring The Resort at Kapalua Bay into its luxury portfolio, reinforcing its focus on high-end leisure destinations. See our latest analysis for Marriott International. The Kapalua Bay agreement lands after a recent earnings update where Marriott reported revenues in line with expectations but earnings per share below analysts' estimates. This mixed outcome was followed...
NYSE:RAMP
NYSE:RAMPSoftware

A Look At LiveRamp (RAMP) Valuation After Predactiv Identity Integration News

Predactiv integration puts LiveRamp’s identity tools in focus LiveRamp Holdings (RAMP) is back in the spotlight after Predactiv announced a new integration that routes offline PII data through LiveRamp’s identity resolution, feeding privacy compliant identifiers into Predactiv’s data platform. This integration, followed by a dedicated LiveRamp special call, raises practical questions for investors about how identity resolution, data collaboration, and monetization of first party PII fit into...
XTRA:TEG
XTRA:TEGReal Estate

TAG Immobilien (XTRA:TEG) Quarterly Loss Challenges Bullish Low P/E Narrative

TAG Immobilien (XTRA:TEG) has just wrapped up FY 2025 with fourth quarter revenue of €331.5 million and a quarterly loss per share of €1.08, while trailing 12 month EPS stands at €0.52 on total revenue of €992.6 million. Over recent periods the company has seen quarterly revenue range from €207.0 million to €331.5 million and basic EPS move between a loss of €1.08 and a profit of €0.85, giving investors a wide view of how earnings and margins have shifted across the year. Taken together, the...
CPSE:NOVO B
CPSE:NOVO BPharmaceuticals

Novo Nordisk Weighs UBT251 Obesity Data Against Weak Share Momentum

Novo Nordisk (CPSE:NOVO B) released phase 2 data for its triple agonist obesity drug UBT251, targeting GLP-1, GIP and glucagon receptors. The trial reported significant weight loss in participants, adding a new contender to the GLP-1 class of obesity treatments. This update arrives as competition in obesity drugs intensifies, with Eli Lilly, Structure Therapeutics and others pursuing rival therapies. Novo Nordisk, trading at DKK241.5, is coming off a weak share price stretch, with the...
NYSE:ANDG
NYSE:ANDGProfessional Services

Andersen Group (ANDG) Margin Compression Challenges Bullish Community Narratives Despite Revenue Growth

Andersen Group FY 2025 earnings snapshot Andersen Group (ANDG) has just wrapped up FY 2025 with fourth quarter revenue of US$170.3 million, a basic EPS loss of US$0.18, and trailing twelve month revenue of US$838.7 million, alongside a trailing net margin of 6.9% versus 18.5% a year earlier. Over the last six reported quarters, revenue has moved from US$639.1 million on a trailing basis in FY 2023 to US$838.7 million in FY 2025. Quarterly net income has swung between profit and loss as...